Track Portage Biotech's receivables ($12K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Portage Biotech (PRTG) currently reports a receivables of $12K as of March 2025. That compares with $39K in the prior-year period — down 69.2% year over year. Use the charts on this page to explore Portage Biotech's receivables history and peer comparisons.
Portage Biotech's receivables decreased from $39K to $12K — a 69.2% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Portage Biotech reported $12K in receivables as of March 2025. That compares with $39K in the prior-year period — down 69.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current receivables of $12K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Portage Biotech, and consider following PRTG for alerts when major investors trade the stock.
Portage Biotech is classified in the Energy sector. On receivables, it currently shows $12K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Energy are usually more informative than comparing PRTG with unrelated industries.